These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4631717)

  • 21. [Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].
    Poloni M; Rocchelli B; Mazzarello P; Delodovici M
    Riv Neurol; 1981; 51(2):69-80. PubMed ID: 7244541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis: an overview, with some observations on the spinal fluid protein.
    Darnell D; Abrams BM; Moroney J
    J Am Osteopath Assoc; 1974 Feb; 73(6):450-4. PubMed ID: 4360489
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of the treatment with encorton (Polfa) on the production of immunoglobulin G in the central nervous system of patients with multiple sclerosis].
    Ochudło S
    Wiad Lek; 1987 Dec; 40(23):1588-92. PubMed ID: 3451587
    [No Abstract]   [Full Text] [Related]  

  • 24. CSF analysis in multiple sclerosis.
    Sindic CJ
    Acta Neurol Belg; 1994; 94(2):103-11. PubMed ID: 8036877
    [No Abstract]   [Full Text] [Related]  

  • 25. [Significance of increased immunoglobulin G levels in the cerebrospinal fluid of patients with multiple sclerosis].
    Out TA; van der Helm HJ
    Ned Tijdschr Geneeskd; 1984 Sep; 128(35):1666-8. PubMed ID: 6483038
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM; Prange AJ; Luijckx GJ
    Ned Tijdschr Geneeskd; 1987 May; 131(22):966-7. PubMed ID: 3299110
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.
    Oger JJ; Antel JP; Kuo HH; Arnason BG
    Ann Neurol; 1982 Feb; 11(2):177-81. PubMed ID: 6462102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis.
    Ellison GW; Myers LW
    Neurology; 1978 Sep; 28(9 Pt 2):132-9. PubMed ID: 213744
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
    Bartosik-Psujek H; Archelos JJ
    J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabbit anti-human CSF IgG. I. Characterization of anti-idiotype antibodies produced against MS CSF and detection of cross-reactive idiotypes in several MS CSF.
    Tachovsky TG; Sandberg-Wollheim M; Baird LG
    J Immunol; 1982 Aug; 129(2):764-70. PubMed ID: 6806382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG-antibodies to CNS proteins in patients with multiple sclerosis.
    Kaiser R; Obert M; Kaufmann R; Czygan M
    Eur J Med Res; 1997 Apr; 2(4):169-72. PubMed ID: 9110924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against HSP70 family proteins were detected in the cerebrospinal fluid from patients with multiple sclerosis.
    Chiba S; Yokota S; Yonekura K; Tanaka S; Furuyama H; Kubota H; Fujii N; Matsumoto H
    J Neurol Sci; 2006 Feb; 241(1-2):39-43. PubMed ID: 16303141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF IgG synthesis rate in multiple sclerosis.
    Neurology; 1987 Dec; 37(12):1886. PubMed ID: 3683885
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multiple sclerosis and oligoclonal IgG bands].
    Nakashima I; Fujihara K; Fujimori J; Misu T; Itoyama Y
    No To Shinkei; 2004 Jun; 56(6):475-82. PubMed ID: 15328836
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system.
    Schubert J; Weissbrich B
    BMC Neurol; 2007 May; 7():12. PubMed ID: 17535416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further observations on the effect of azathioprine on chronic nonremitting multiple sclerosis.
    Rosen JA
    Trans Am Neurol Assoc; 1978; 103():209-12. PubMed ID: 757060
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 39. [Side effects of azathioprine (Imurel). Apropos of 313 patients treated for multiple sclerosis. Review of the literature].
    Ventre JJ; Guillot M; Confavreux C; Evreux JC; Aimard G
    Therapie; 1985; 40(3):195-202. PubMed ID: 4012666
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term treatment of multiple sclerosis with azathioprine.
    Swinburn WR; Liversedge LA
    J Neurol Neurosurg Psychiatry; 1973 Feb; 36(1):124-6. PubMed ID: 4632435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.